Search for:

Binxin Li

Binxin heads the patent team in China. He supports his clients’ business operations and commercial growth in China and overseas by delivering practical and comprehensive solutions that utilize his clients’ IP assets as well as advising on the prevention of potential legal risks. He advises multinational and domestic companies in the pharmaceutical, chemical, mechanical, telecommunication and entertainment industries on complex IP issues related to prosecution, portfolio management, enforcement, and IP utilization.

On 22 March 2022, the Ministry of Science and Technology of the People’s Republic of China issued Draft Implementation Rules of the Administrative Regulations on Human Genetic Resources for public comments until 21 April 2022. The Draft Rules provide clarifications and operational details on the Administrative Regulations on Human Genetic Resources promulgated in 2019.

The Guide to Doing Business in China provides an introduction to selected aspects relating to investment and business operations in the People’s Republic of China under current Chinese laws and policy during the COVID pandemic, including a summary of important areas of concern to all investors in China: mergers and acquisitions, data privacy issues, antitrust and competition issues, taxation, employment, intellectual property protection, trade and import and export rules, financial services, as well as anti-bribery compliance and dispute resolution issues.

Financial institutions are leading the way in adopting new technologies such as machine learning, AI and “big data.” These and other technologies now play an integral role in a range of operations, from portfolio management to fraud prevention, from executing trades to transforming the customer experience. While the potential is…